Literature DB >> 34417839

The relationship between transforming growth factor β superfamily members (GDF11 and BMP4) and lumbar spine bone mineral density in postmenopausal Chinese women.

Wen Han1, Xiao-Juan Bai2, Lu-Lu Han1, Xiang-Mei Chen3, Xue-Feng Sun3.   

Abstract

PURPOSE: The relationship between transforming growth factor β superfamily members (GDF11 and BMP4) and bone metabolism remains controversial. The aim of this study was to investigate the association between serum GDF11 and BMP4 levels and lumbar spine bone mineral density (LBMD) in a cohort of postmenopausal Chinese women.
METHODS: This was a non-prospective cross-sectional study of 350 postmenopausal women with a mean age of 63.13 ± 8.66 years who came from Shenyang, China. LBMD was measured using dual-energy X-ray absorptiometry. Serum GDF11 and BMP4 concentrations were detected using a sandwich enzyme immunoassay kit. Pearson's correlation analysis and regression analyses were carried out to investigate the relationships between LBMD and serum GDF11 and BMP4 levels.
RESULTS: A linear association between LBMD and serum LgGDF11 concentration was observed after adjusting for numerous confounders (P = 0.018). In addition, the osteoporosis (OP) was inversely related to LgGDF11 and the odds ratios for postmenopausal women with lumbar OP in LgGDF11 quartile group 2, group 3, and group 4 were 0.46 (95% CI 0.23-0.90, P < 0.05), 0.41 (95% CI 0.20-0.84, P < 0.05), and 0.30 (95% CI 0.14-0.63, P < 0.01), respectively (P = 0.001 for the trend), when compared to the highest quartile of LgGDF11 after adjustments for many confounding variables in this study.
CONCLUSIONS: This study showed that serum GDF11 levels were linearly related to LBMD, and it was also revealed that serum GDF11 levels were significantly associated with lumbar OP in postmenopausal women. However, serum BMP4 levels were not associated with LBMD and lumbar OP.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Lumbar bone mineral density; Postmenopausal women; Serum BMP4 levels; Serum GDF11 levels

Mesh:

Substances:

Year:  2021        PMID: 34417839     DOI: 10.1007/s00404-021-06183-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  22 in total

1.  GDF11 Inhibits Bone Formation by Activating Smad2/3 in Bone Marrow Mesenchymal Stem Cells.

Authors:  Qiong Lu; Man-Li Tu; Chang-Jun Li; Li Zhang; Tie-Jian Jiang; Tang Liu; Xiang-Hang Luo
Journal:  Calcif Tissue Int       Date:  2016-07-09       Impact factor: 4.333

2.  Transgenic over-expression of growth differentiation factor 11 propeptide in skeleton results in transformation of the seventh cervical vertebra into a thoracic vertebra.

Authors:  Zicong Li; Miyuri Kawasumi; Baoping Zhao; Stefan Moisyadi; Jinzeng Yang
Journal:  Mol Reprod Dev       Date:  2010-11       Impact factor: 2.609

3.  GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration.

Authors:  Marc A Egerman; Samuel M Cadena; Jason A Gilbert; Angelika Meyer; Hallie N Nelson; Susanne E Swalley; Carolyn Mallozzi; Carsten Jacobi; Lori L Jennings; Ieuan Clay; Gaëlle Laurent; Shenglin Ma; Sophie Brachat; Estelle Lach-Trifilieff; Tea Shavlakadze; Anne-Ulrike Trendelenburg; Andrew S Brack; David J Glass
Journal:  Cell Metab       Date:  2015-05-19       Impact factor: 27.287

4.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

5.  Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning.

Authors:  S Paul Oh; Chang-Yeol Yeo; Youngjae Lee; Heindrich Schrewe; Malcolm Whitman; En Li
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

6.  Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors.

Authors:  Lida Katsimpardi; Nadia K Litterman; Pamela A Schein; Christine M Miller; Francesco S Loffredo; Gregory R Wojtkiewicz; John W Chen; Richard T Lee; Amy J Wagers; Lee L Rubin
Journal:  Science       Date:  2014-05-05       Impact factor: 47.728

7.  Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle.

Authors:  Manisha Sinha; Young C Jang; Juhyun Oh; Danika Khong; Elizabeth Y Wu; Rohan Manohar; Christine Miller; Samuel G Regalado; Francesco S Loffredo; James R Pancoast; Michael F Hirshman; Jessica Lebowitz; Jennifer L Shadrach; Massimiliano Cerletti; Mi-Jeong Kim; Thomas Serwold; Laurie J Goodyear; Bernard Rosner; Richard T Lee; Amy J Wagers
Journal:  Science       Date:  2014-05-05       Impact factor: 47.728

8.  Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma.

Authors:  Yan Zhang; Jin Shao; Zhi Wang; Tieyi Yang; Shuyi Liu; Yue Liu; Xinbing Fan; Weiguang Ye
Journal:  Gene       Date:  2014-12-20       Impact factor: 3.688

9.  Transgenic overexpression of bone morphogenetic protein 11 propeptide in skeleton enhances bone formation.

Authors:  Zicong Li; Fang Zeng; Alva D Mitchell; Yong Soo Kim; Zhenfang Wu; Jinzeng Yang
Journal:  Biochem Biophys Res Commun       Date:  2011-11-10       Impact factor: 3.575

10.  Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy.

Authors:  Francesco S Loffredo; Matthew L Steinhauser; Steven M Jay; Joseph Gannon; James R Pancoast; Pratyusha Yalamanchi; Manisha Sinha; Claudia Dall'Osso; Danika Khong; Jennifer L Shadrach; Christine M Miller; Britta S Singer; Alex Stewart; Nikolaos Psychogios; Robert E Gerszten; Adam J Hartigan; Mi-Jeong Kim; Thomas Serwold; Amy J Wagers; Richard T Lee
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.